About: Aldoxorubicin

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Aldoxorubicin (INNO-206) is a tumor-targeted doxorubicin conjugate in development by CytRx. Specifically, it is the (6-maleimidocaproyl) hydrazone of doxorubicin. Essentially, this chemical name describes doxorubicin attached to an acid-sensitive linker (N-ε-maleimidocaproic acid hydrazide, or EMCH). The proposed mechanism of action is as follows:

Property Value
dbo:abstract
  • Aldoxorubicin (INNO-206) is a tumor-targeted doxorubicin conjugate in development by CytRx. Specifically, it is the (6-maleimidocaproyl) hydrazone of doxorubicin. Essentially, this chemical name describes doxorubicin attached to an acid-sensitive linker (N-ε-maleimidocaproic acid hydrazide, or EMCH). The proposed mechanism of action is as follows: 1. * After administration, aldoxorubicin rapidly binds endogenous circulating albumin through the EMCH linker. 2. * Circulating albumin preferentially accumulates in tumors, bypassing uptake by other non-specific sites including heart, bone marrow and gastrointestinal tract. 3. * Once albumin-bound aldoxorubicin reaches the tumor, the acidic environment of the tumor causes cleavage of the acid sensitive linker. 4. * Free doxorubicin is released at the site of the tumor. (en)
dbo:casNumber
  • 1361644-26-9
dbo:fdaUniiCode
  • C28MV4IM0B
dbo:kegg
  • D10383
dbo:pubchem
  • 71300693
dbo:thumbnail
dbo:wikiPageID
  • 45717219 (xsd:integer)
dbo:wikiPageLength
  • 7520 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1038323173 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 37 (xsd:integer)
dbp:casNumber
  • 1361644 (xsd:integer)
dbp:chemspiderid
  • 7986464 (xsd:integer)
dbp:h
  • 42 (xsd:integer)
dbp:iupacName
  • N-1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide (en)
dbp:kegg
  • D10383 (en)
dbp:n
  • 4 (xsd:integer)
dbp:o
  • 13 (xsd:integer)
dbp:pubchem
  • 71300693 (xsd:integer)
dbp:smiles
  • C[C@H]1[C@H]O (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • OBMJQRLIQQTJLR-FRTGXRTISA-N (en)
dbp:unii
  • C28MV4IM0B (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Aldoxorubicin (INNO-206) is a tumor-targeted doxorubicin conjugate in development by CytRx. Specifically, it is the (6-maleimidocaproyl) hydrazone of doxorubicin. Essentially, this chemical name describes doxorubicin attached to an acid-sensitive linker (N-ε-maleimidocaproic acid hydrazide, or EMCH). The proposed mechanism of action is as follows: (en)
rdfs:label
  • Aldoxorubicin (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License